{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:01:46Z","timestamp":1779998506822,"version":"3.53.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Benioff Homelessness and Housing Initiative"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R01AI169667"],"award-info":[{"award-number":["5R01AI169667"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R37AI098472"],"award-info":[{"award-number":["5R37AI098472"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["IN-US-985-6867"],"award-info":[{"award-number":["IN-US-985-6867"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human immunodeficiency virus (HIV) viral suppression remains suboptimal among people with HIV (PWH) facing barriers such as homelessness, substance use, and mental health disorders. In 2019, Ward 86 launched the POP-UP program, a low-barrier HIV care model serving PWH with unstable housing and difficulty engaging in care. In 2021, we introduced long-acting antiretroviral therapy (LA-ART), including for PWH unable to attain viral suppression on oral antiretroviral therapy. This study evaluates temporal trends in viral suppression and mortality rates within the POP-UP program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of PWH enrolled in the POP-UP program between August 2019 and December 2024. Eligibility included viremia (HIV viral load \u2265200\u2005copies\/mL) or being off antiretroviral therapy, homelessness\/unstable housing, and difficulty engaging in care. Criteria later expanded to include PWH with severe mental health or substance use disorders. The primary outcomes were viral suppression (&amp;lt;200\u2005copies\/mL) and death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 241 PWH ever enrolled in POP-UP, 86% attained viral suppression at least once during follow-up. Cross-sectional viral suppression was 47% in August 2019 (8 months after program inception) and increased to 64% in December 2024. By December 2024, 46% of suppressed patients were on LA-ART. The mortality rate declined from 8.8\/100 person-years in 2020 to 2.6\/100 person-years in 2024, with reductions in both AIDS-related and overdose deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The POP-UP program improved viral suppression and may have reduced the mortality rate among PWH with substantial barriers to care. Improvements were likely driven by integration of LA-ART and continued quality improvement. Persistent viremia within the program highlights the need for additional strategies to address structural and psychosocial barriers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag263","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:25:11Z","timestamp":1777577111000},"source":"Crossref","is-referenced-by-count":0,"title":["Trends in HIV Viral Suppression in the POP-UP Low-Barrier Care Program for People With HIV Experiencing Homelessness or Unstable Housing"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3060-3596","authenticated-orcid":false,"given":"Elizabeth","family":"Imbert","sequence":"first","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Fleming","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Oskarsson","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caycee","family":"Cullen","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Shiels","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Friend","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joi","family":"Jackson","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Felten","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Zahedikia","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Alliance Health Project, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liria","family":"Santos","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Mayorga-Munoz","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesenia","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yenifer","family":"Breganza","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Grochowski","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cohen","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4602-5954","authenticated-orcid":false,"given":"Ayesha","family":"Appa","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Koester","sequence":"additional","affiliation":[{"name":"Center for AIDS Prevention Studies, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7632-0321","authenticated-orcid":false,"given":"Xavier","family":"Erguera","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7237-2119","authenticated-orcid":false,"given":"Edwin","family":"Charlebois","sequence":"additional","affiliation":[{"name":"Center for AIDS Prevention Studies, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7025-1994","authenticated-orcid":false,"given":"Monica","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane V","family":"Havlir","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-2191","authenticated-orcid":false,"given":"Katerina","family":"Christopoulos","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8913-1602","authenticated-orcid":false,"given":"Matthew D","family":"Hickey","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2026052815023358100_ofag263-B1","article-title":"Core indicators for monitoring the ending the HIV epidemic initiative: national HIV surveillance system data reported through December 2023","volume":"5","author":"Centers for Disease Control and Prevention","year":"2024","journal-title":"HIV Surveillance Data Tables"},{"key":"2026052815023358100_ofag263-B2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12889-020-8442-1","article-title":"Sustained HIV viral suppression among men who have sex with men in the Miami-Dade County Ryan White program: the effect of demographic, psychosocial, provider and neighborhood factors","volume":"20","author":"Sheehan","year":"2020","journal-title":"BMC Public Health"},{"key":"2026052815023358100_ofag263-B3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12913-017-2219-y","article-title":"Interventions to reduce wait times for primary care appointments: a systematic review","volume":"17","author":"Ansell","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2026052815023358100_ofag263-B4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11904-020-00488-0","article-title":"Improving care outcomes for PLWH experiencing homelessness and unstable housing: a synthetic review of clinic-based strategies","volume":"17","author":"Clemenzi-Allen","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2026052815023358100_ofag263-B5","doi-asserted-by":"crossref","first-page":"ofz294","DOI":"10.1093\/ofid\/ofz294","article-title":"HIV care for patients with complex needs: a controlled evaluation of a walk-in, incentivized care model","volume":"6","author":"Dombrowski","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2026052815023358100_ofag263-B6","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1093\/infdis\/jiac267","article-title":"HIV treatment outcomes in POP-UP: drop-in HIV primary care model for people experiencing homelessness","volume":"226","author":"Hickey","year":"2022","journal-title":"J Infect Dis"},{"key":"2026052815023358100_ofag263-B7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/apc.2024.0228","article-title":"POP-UP Mobile: a mixed methods study of mobile outreach for people with HIV with housing instability who are out of care from a low-barrier clinical program in San Francisco","volume":"39","author":"Conte","year":"2025","journal-title":"AIDS Patient Care STDs"},{"issue":"S7","key":"2026052815023358100_ofag263-B8","doi-asserted-by":"crossref","first-page":"S528","DOI":"10.2105\/AJPH.2018.304732","article-title":"Mobile multidisciplinary HIV medical care for hard-to-reach individuals experiencing homelessness in San Francisco","volume":"108","author":"Borne","year":"2018","journal-title":"Am J Public Health"},{"key":"2026052815023358100_ofag263-B9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247328","article-title":"Barriers and facilitators to use of a mobile HIV care model to re-engage and retain out-of-care people living with HIV in Atlanta, Georgia","volume":"16","author":"Henkhaus","year":"2021","journal-title":"PLoS One"},{"key":"2026052815023358100_ofag263-B10","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/S2352-3018(22)00031-5","article-title":"Equity in access to long-acting injectables in the USA","volume":"9","author":"Hojilla","year":"2022","journal-title":"Lancet HIV"},{"key":"2026052815023358100_ofag263-B11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/cid\/ciae500","article-title":"Viral suppression rates at 48 weeks in people with HIV starting long-acting cabotegravir\/rilpivirine with initial viremia","volume":"80","author":"Hickey","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026052815023358100_ofag263-B12","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents"},{"key":"2026052815023358100_ofag263-B13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.2024.24543","article-title":"Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the international antiviral society-USA panel","volume":"333","author":"Gandhi","year":"2025","journal-title":"JAMA"},{"key":"2026052815023358100_ofag263-B14","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/QAD.0000000000002843","article-title":"Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing","volume":"35","author":"Imbert","year":"2021","journal-title":"AIDS Lond Engl"},{"key":"2026052815023358100_ofag263-B15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/QAI.0000000000002476","article-title":"Brief report: understanding preferences for HIV care among patients experiencing homelessness or unstable housing: a discrete choice experiment","volume":"85","author":"Conte","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026052815023358100_ofag263-B16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/QAI.0000000000002929","article-title":"Brief report: heterogeneous preferences for care engagement among people with HIV experiencing homelessness or unstable housing during the COVID-19 pandemic","volume":"90","author":"Imbert","year":"2022","journal-title":"J Acquir Immune Defic Syndr."},{"key":"2026052815023358100_ofag263-B17","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1093\/cid\/ciac631","article-title":"First demonstration project of long-acting injectable antiretroviral therapy for persons with and without detectable HIV viremia in an urban HIV clinic","volume":"76","author":"Christopoulos","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026052815023358100_ofag263-B18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/M23-0788","article-title":"Demonstration project of long-acting antiretroviral therapy in a diverse population of people with HIV","volume":"176","author":"Gandhi","year":"2023","journal-title":"Ann Intern Med"},{"key":"2026052815023358100_ofag263-B19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/QAI.0000000000003421","article-title":"Identifying implementation determinants and strategies for long-acting injectable cabotegravir-rilpivirine in people with HIV who are virally unsuppressed","volume":"96","author":"Hickey","year":"2024","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026052815023358100_ofag263-B20","author":"Gandhi"},{"key":"2026052815023358100_ofag263-B21","volume-title":"HIV epidemiology annual report 2024","author":"Tsai","year":"2025"},{"key":"2026052815023358100_ofag263-B22","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2025.0109","article-title":"HIV viral suppression with use of long-acting antiretroviral therapy in people with and without initial viremia","volume":"333","author":"Spinelli","year":"2025","journal-title":"JAMA"},{"key":"2026052815023358100_ofag263-B23","doi-asserted-by":"crossref","first-page":"e26394","DOI":"10.1002\/jia2.26394","article-title":"Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir\/rilpivirine among early adopters in three U.S. clinics","volume":"27","author":"Christopoulos","year":"2024","journal-title":"J Int AIDS Soc"},{"key":"2026052815023358100_ofag263-B24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214636","article-title":"The influence of the \u2018good\u2019 patient ideal on engagement in HIV care","volume":"14","author":"Koester","year":"2019","journal-title":"PLoS One"},{"key":"2026052815023358100_ofag263-B25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12875-024-02410-8","article-title":"The association between population health management tools and clinician burnout in the United States VA primary care patient-centered medical home","volume":"25","author":"Wang","year":"2024","journal-title":"BMC Prim Care"},{"key":"2026052815023358100_ofag263-B26"},{"key":"2026052815023358100_ofag263-B27","author":"Centers for Disease Control and Prevention"},{"key":"2026052815023358100_ofag263-B28","first-page":"82:e728-e734.","article-title":"Integrating HIV and stimulant-use disorder treatment: a pilot implementation effectiveness trial of contingency management in HIV care","author":"Appa","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026052815023358100_ofag263-B29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10461-005-9000-7","article-title":"Housing status and HIV risk behaviors: implications for prevention and policy","volume":"9","author":"Aidala","year":"2005","journal-title":"AIDS Behav"},{"key":"2026052815023358100_ofag263-B30","doi-asserted-by":"crossref","first-page":"101673","DOI":"10.1016\/j.evalprogplan.2019.101673","article-title":"\u201cIf you\u2019re gonna help me, help me\u201d: barriers to housing among unsheltered homeless adults","volume":"76","author":"Wusinich","year":"2019","journal-title":"Eval Program Plann"},{"key":"2026052815023358100_ofag263-B31","article-title":"A systems level approach to innovative HIV care and treatment models in the United States: street medicine and differentiated service delivery","year":"2023","journal-title":","},{"key":"2026052815023358100_ofag263-B32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12981-021-00398-0","article-title":"HIV care coordination promotes care re-engagement and viral suppression among people who have been out of HIV medical care: an observational effectiveness study using a surveillance-based contemporaneous comparison group","volume":"18","author":"Irvine","year":"2021","journal-title":"AIDS Res Ther"},{"key":"2026052815023358100_ofag263-B33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/QAD.0000000000003411","article-title":"HTPN 078: an enhanced case management study to achieve viral suppression among viremic HIV-positive men who have sex with men in the United States","volume":"37","author":"Remien","year":"2023","journal-title":"AIDS Lond Engl"},{"key":"2026052815023358100_ofag263-B34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/COH.0000000000000904","article-title":"Use of long-acting injectable cabotegravir\/rilpivirine in people with HIV and adherence challenges","volume":"20","author":"Christopoulos","year":"2025","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag263\/68197516\/ofag263.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/5\/ofag263\/68197516\/ofag263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/5\/ofag263\/68197516\/ofag263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T19:02:40Z","timestamp":1779994960000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag263\/8665973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag263","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,28]]},"article-number":"ofag263"}}